BROSSARD, QUEBEC, CANADA--(Marketwire - June 11, 2012) - DIAGNOS inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence ("AI") and advanced knowledge extraction techniques, is pleased to announce the appointment of Mr. Philip Renaud as Executive Chairman of the Company's Board of Directors.
Mr. Renaud has served as Chairman of the DIAGNOS Board of Directors since December 2009. As Executive Chairman, Mr. Renaud will take an active role in the Company and will continue to work closely with DIAGNOS President and Chief Executive Officer, André Larente, and the management team, in executing the business plans for the Company's lead products CARA® (Computer Assisted Retinal Analysis) and CARDS® (Computer Aided Resources Detection System). He will also focus more directly on strategic planning, corporate development and corporate governance.
"We are pleased that Philip has agreed to serve as Executive Chairman at this critical point in the Company's growth," said André Larente, President and Chief Executive Officer of DIAGNOS. "I have worked very closely with Philip over the past several years, and he has been intimately involved with the management team. Philip has a long record of success in the business community, and his insights and extensive executive-level experience will continue to be tremendous assets as we move forward with our growth and development initiatives."
"It is a privilege to have been asked by my fellow Board members to serve as Executive Chairman of DIAGNOS at this important stage of the Company's development," said Mr. Renaud. "I look forward to working with André and the management team as we continue to advance and work together to build value for shareholders."
Mr. Renaud is Managing Director of Church Advisors, a European investment advisory firm involved in private financings. A graduate of Franklin College of Switzerland with a Bachelor of Arts in international financial management, Mr. Renaud has been instrumental in securing many private equity financings and has an extensive European and North American network. Mr. Renaud is also Chairman of Kane Biotech inc., a biotechnology company and Director of Dia Bras Exploration Inc. and Yorbeau Resources Inc., two public minerals exploration companies.
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE:ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare, natural resources, and entertainment.
DIAGNOS can count on a multidisciplinary team that includes professionals in geophysics, geology, Artificial Intelligence, mathematics, as well as remote sensing and image interpretation. The Corporation's objective is to develop a royalty stream by significantly enhancing and participating in the exploration success rate of mining. For further information, please visit our Website at www.diagnos.com.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.